new_0222_0608|SBTX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0608|SBTX|Long Name|1|1|Silverback Therapeutics Inc Total Current Assets (Quarterly) (USD)|Silverback Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Silverback Therapeutics Inc Inventories (Quarterly) (USD)|Silverback Therapeutics Inc Net PP&E (Quarterly) (USD)|Silverback Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Silverback Therapeutics Inc Total Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Silverback Therapeutics Inc Total Deposits (Quarterly) (USD)|Silverback Therapeutics Inc Book Value (Quarterly) (USD)|Silverback Therapeutics Inc Retained Earnings (Quarterly) (USD)|Silverback Therapeutics Inc Treasury Stock (Quarterly) (USD)|Silverback Therapeutics Inc EV to Revenues|Silverback Therapeutics Inc EV to Earnings|Silverback Therapeutics Inc EV to Free Cash Flow|Silverback Therapeutics Inc EV to Assets (Quarterly)|Silverback Therapeutics Inc PS Ratio|Silverback Therapeutics Inc PE Ratio|Silverback Therapeutics Inc Price to Book Value|Silverback Therapeutics Inc PEG Ratio|Silverback Therapeutics Inc Debt to Equity Ratio|Silverback Therapeutics Inc Dividend Yield|Silverback Therapeutics Inc Shareholder Yield (TTM)|Silverback Therapeutics Inc Percent of Shares Outstanding Short|Silverback Therapeutics Inc Total Receivables (Quarterly) (USD)|Silverback Therapeutics Inc Total Payables (Quarterly) (USD)|Silverback Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Silverback Therapeutics Inc Return on Invested Capital|Silverback Therapeutics Inc Quality Ratio Score|Silverback Therapeutics Inc Momentum Score|Silverback Therapeutics Inc Beta (1Y)|Silverback Therapeutics Inc Sustainable Growth Rate (TTM)|Silverback Therapeutics Inc Institutional Investor Ownership Percentage|Silverback Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Silverback Therapeutics Inc Total Employees (Annual)|Silverback Therapeutics Inc EPS Diluted (Quarterly) (USD)|Silverback Therapeutics Inc SG&A Expense (Quarterly) (USD)|Silverback Therapeutics Inc Shares Outstanding|Silverback Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Silverback Therapeutics Inc Ordinary Shares Number (Quarterly)|Silverback Therapeutics Inc Payout Ratio|Silverback Therapeutics Inc Quick Ratio (Quarterly)|Silverback Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Silverback Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Silverback Therapeutics Inc Effective Tax Rate (TTM)|Silverback Therapeutics Inc Return on Equity|Silverback Therapeutics Inc Net Income (TTM) (USD)|Silverback Therapeutics Inc Revenue (TTM) (USD)|Silverback Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Silverback Therapeutics Inc Revenue (Quarterly) (USD)|Silverback Therapeutics Inc Gross Profit (Quarterly) (USD)|Silverback Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Silverback Therapeutics Inc Net Income (Quarterly) (USD)|Silverback Therapeutics Inc Net Interest Income (Quarterly) (USD)|Silverback Therapeutics Inc Price (USD)|Silverback Therapeutics Inc Total Return Price (USD)|Silverback Therapeutics Inc Enterprise Value (USD)|Silverback Therapeutics Inc 30-Day Average Daily Volume|Silverback Therapeutics Inc 1 Year Price Returns (Daily)|Silverback Therapeutics Inc Short Interest|Silverback Therapeutics Inc PE Ratio (Forward)|Silverback Therapeutics Inc PE Ratio (Forward 1y)|Silverback Therapeutics Inc PS Ratio (Forward)|Silverback Therapeutics Inc PS Ratio (Forward 1y)|Silverback Therapeutics Inc Quarterly EPS Estimates (USD)|Silverback Therapeutics Inc Quarterly Revenue Estimates (USD)|Silverback Therapeutics Inc Quarterly EPS Surprise|Silverback Therapeutics Inc Quarterly Revenue Surprise|Silverback Therapeutics Inc Quarterly Actual EPS (USD)|Silverback Therapeutics Inc Quarterly Actual Revenue (USD)|Silverback Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Silverback Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Silverback Therapeutics Inc Price Target (USD)|Silverback Therapeutics Inc Consensus Recommendation|Silverback Therapeutics Inc Price Target Num Estimates|Silverback Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Silverback Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Silverback Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Silverback Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Silverback Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Silverback Therapeutics Inc Land and Improvements (Quarterly) (USD)|Silverback Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Silverback Therapeutics Inc Other Properties (Quarterly) (USD)|Silverback Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0608|SBTX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0608|SBTX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0608|SBTX||5|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.44755244755|0|0|0|1.44755244755|0|0|1.45065789474|0|15.2592592593|0|127.8|127.8|0|0|0|31|0|0|91.2857142857|121.666666667|91.2857142857|91.2857142857|28.5833333333|0|127.8|0|0|91.2857142857|0|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|1.45065789474|1.45065789474|1.45065789474|1.43636363636|1.42307692308|15.2592592593|0|0|0|0|91.3|91.25|91|0|91|91|106|35.3333333333|22.7142857143|16.7368421053|22.7142857143|52.8333333333|52.8333333333|91.2857142857|91.2857142857|0|0|0|127.8|183
new_0222_0608|SBTX||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|286|0|0|0|286|0|0|304|0|27|0|5|5|0|0|0|1|0|0|7|3|7|7|12|0|5|0|0|7|0|0|0|4|0|0|0|0|7|7|7|304|304|304|275|52|27|0|0|0|0|10|8|3|0|3|3|3|9|14|19|14|6|6|7|7|0|0|0|5|2
new_0222_0608|SBTX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0608|SBTX|201912|201912|201912|10.528|9.976||4.569||74.424|17.926|56.498||-58.777|-63.787|||||||||||||||3.518|0|||||||9.2554||-0.7531|0.658|||28.5167|||-0.7531|||||||||-6.97|-6.97|-0.039||||||||||||||||||||||||6.273|0.138||||5.863|0.156
new_0222_0608|SBTX|202003|202003|202003||||||||||||||||||||||||||||||||||9.2554||-0.5704|0.828||||||-0.5704|||||||||-5.279|-5.279|-0.037|||||||||||-0.18|||||||||||||4.414|0.139|||||
new_0222_0608|SBTX|202006|202006|202006||||||||||||||||||||||||||||||||||9.2554||-0.6987|1.337||||||-0.6987|||||||||-6.467|-6.467|-0.004|||||||||||-0.28|||||||||||||5.126|0.138|||||
new_0222_0608|SBTX|202009|202009|202009|143.182|142.317||4.159||227.16|8.005|219.155||-78.249|-83.649|||||||||||||||2.157|0|||||||28.5167|52|-0.2846|1.912|||28.5167|||-0.2846||||-26.832|||||-8.116|-8.116|-0.004|||||||||||-0.46|||||||||||||6.2|0.171||||4.159|
new_0222_0608|SBTX|202011|202009|202009||||||||||||||||||||||||||||||||||||||28.5167||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0608|SBTX|202012|202012|202012|390.656|386.569||3.798||11.927|9.601|2.326||382.877|-96.734||||-38.0635||||4.1999|||0||1.9849||2.583|0.003|||||||34.7013|54|-1.37|4.264|34.7013||34.7013|||-1.37||||-32.947|||||-13.085|-13.085|0.016|46.34|46.34|1222.3332|||688800|||||-0.405|0|7.163||-0.376|0|0|0|46.25|1.5|4|-1.185|-1.83|8.837|0.189||||5.581|0.269
new_0222_0608|SBTX|202101|202012|202012|||||||||||||||-35.4485||||3.9806|||0||2.8092|||||||||||||||||||||||||||||||43.92|43.92|1138.3561|178883.3||974838||||||||||||||||||||||||
new_0222_0608|SBTX|202102|202012|202012|||||||||||||||-39.9221||||4.3558|||0||6.2663||||||||||||||34.8944|||||||||||||||||48.06|48.06|1282.0195|174852.7||2174478||||||||||||||1.5||||||||||
new_0222_0608|SBTX|202103|202103|202103|378.346|374.205||3.503||13.65|11.595|2.055||368.549|-115.601||||-31.2309||||4.123|||0||8.6424||4.374|0.003|||||||34.7739||-0.54|6.646|34.8272||34.8272|||-0.54||||-46.535|||||-18.867|-18.867|0.018|43.63|43.63|1145.8007|307328.6667||3009918|||||-0.39|0|-38.4615||-0.54|0|0|0|50|1.5|4|-1.875|-2.71|12.239|0.186||||3.503|
new_0222_0608|SBTX|202104|202103|202103|||||||||||||||-20.3049||||3.0353|||0||8.7885||||||||||||||34.9035|||||||||||||||||32.05|32.05|744.9472|262027.6667||3067481|||||||||||||52.25|1.5|4|||||||||
new_0222_0608|SBTX|202105|202103|202103|||||||||||||||-16.0063||||2.6074|||0||9.1408||||||||||||||34.9055|||||||||||||||||27.53|27.53|587.2384|134090.2333||3190648|||||||||||0|0|49.5|1.5|4|-2.3667|-3.1067|||||||
new_0222_0608|SBTX|202106|202106|202106|363.027|359.689||3.599||17.326|15.548|1.778||349.65|-140.097||||-15.6337||||3.0888|||0||9.1346||1.805|0.004|||||||34.876|76|-0.7|6.762|34.9631||34.9631|||-0.7||||-64.564|||||-24.496|-24.496|0.015|30.89|30.89|720.3212|129388.3667||3193742|||||-0.5633|0|-24.2611||-0.7|0||||||||17.749|0.207||||3.599|
new_0222_0608|SBTX|202107|202106|202106|||||||||||||||-15.1708||||3.0278|||0||9.1931|||||||||||||||||||||||||||||||30.28|30.28|698.9937|132515.4667||3214198|||||||||||||49.5|1.5|4|||||||||
new_0222_0608|SBTX|202108|202106|202106|||||||||||||||-8.9227||||2.2045|||0||9.3399||||||||||||||35.0365|||||||||||||||||22|22|411.114|167226.4667||3272357||||||||||||0|50|1.5|4|-2.6767|-3.7067|||||||
new_0222_0608|SBTX|202109|202109|202109|305.355|300.66||6.918||20.427|15.347|5.08||332.134|-162.752||||-0.8506||||1.0528|||0||11.4893||1.72|0.004|||||||35.0015|83|-0.65|7.04|35.0371||35.0371|||-0.65||||-79.103|||||-22.655|-22.655|0.026|9.98|9.98|49.0103|589091.1333||4025539|||||-0.7|0|0||-0.7|0||0|44.25|1.5|4|||15.641|0.203||||6.918|
new_0222_0608|SBTX|202110|202109|202109|||||||||||||||-0.0297||||0.9104|||0||11.0653|||||||||||||||||||||||||||||||8.63|8.63|1.7102|452639.1||3876960||||||||||||0|44.25|1.5|4|-2.6767|-3.7067|||||||
new_0222_0608|SBTX|202111|202109|202109|||||||||||||||0.9385||||0.7424|||0||6.2854||||||||||||||35.0761|||||||||||||||||7.03|7.03|-54.075|378990.2333||2204674|||||||||||0|0|33.5|1.5|4|-2.3967|-3.1967|||||||
new_0222_0608|SBTX|202112|202112|202112|||||||||||||||1.1637||||0.7034|||0||4.4791|||||||2.367||||||||||||||||||||||||6.66|6.66|-67.0532|453870.3|-85.628|1573668|||||-0.6333|0||||||||||||||||||
new_0222_0608|SBTX|202201|202112|202112|||||||||||||||2.2534||||0.5143|||0||4.7044||||||1|2.4918||||||||||||||||||||||||4.87|4.87|-129.8394|358571.0333|-88.9117|1652829||||||||||||||||||||||||
new_0222_0608|SBTX|202202|202112|202112|||||||||||||||2.856||||0.4098|||0|||||||||||||||||||||||||||||||||3.88|3.88|-164.5647|294759.3333|-91.9835|||||||||||||||||||||||||
new_0222_0608|SBTX|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.66|0||||||||||||||||||
new_0222_0608|SBTX|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.86|0||||||||||||||||||
new_0222_0608|SBTX|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.79|0||||||||||||||||||
new_0222_0608|SBTX|202212|202212|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||